🔎 Trials Near Me

Utama › Kegagalan Jantung › West Virginia

Kajian klinikal Kegagalan Jantung di West Virginia

8 kajian untuk Kegagalan Jantung sedang mencari peserta di lokasi di West Virginia.

Bandar di West Virginia

Teks kajian rasmi (Bahasa Inggeris)

ELEVATE-HFpEF Clinical Study

  • Charleston Area Medical Center (CAMC) Memorial Hospital, Charleston
Mengambil peserta
Umur 40 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06678841

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Kingwood
  • Research Site, Morgantown
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07761117

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Kingwood
  • Research Site, Morgantown
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06677060

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • WVU Medicine, Morgantown
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07567001

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • West Virginia University, Morgantown
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT05934487

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  • West Virginia Childrens Hospital, Morgantown
  • West Virginia Childrens Hospital, Morgantown
Mengambil pesertaFasa 3
Umur 6 hingga 11 · Semua jantina · Dikemas kini 15 Mei 2026 · NCT06597019

Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients

  • West Virginia School of Osteopathic Medicine, Lewisburg
Mengambil peserta
Umur 18 hingga 64 · Semua jantina · Dikemas kini 25 Jul 2025 · NCT06049420

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.